Peptide Initiative

Peptide profile · Healing & Recovery

BPC-157

The "Wolverine peptide" known for its remarkable healing properties across tendons, ligaments, muscles, and the gut.

Strong preclinicalResearch compound
4-6 hoursHalf-life
~100%Bioavailability (subcutaneous)
1419.53Molecular weight, g/mol

Molecular formula

C62H98N16O22

CAS number
137525-51-0
PubChem
9941444
Developed · 1992
Predrag Sikirić, University of Zagreb

Amino acid sequence

Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

Primary benefitAccelerates wound healing

8.5

Secondary benefitPromotes tendon repair

7.8

Additional benefitPromotes ligament repair

7.2

Ratings out of 10.

250 – 500mcg

Every documented dose level

PhaseDoseFrequency
Weeks 1-2250 mcgOnce daily
Weeks 4-6250-500 mcgTwice daily
Weeks 6-8500 mcgTwice daily
Build my protocolBuild my protocol opens your schedule and dose log to save, share and keep on your phone.

Best for injury recovery & post-surgery healing

Best for

  • Tendon and ligament injuries

    Sprains, strains, tears, tendinitis - BPC-157 accelerates collagen synthesis and tissue repair

  • Gut healing

    IBS, leaky gut, ulcers, inflammatory bowel conditions - derived from gastric juice, it has a natural affinity for digestive tissue

  • Muscle injuries

    Strains, post-workout recovery, chronic muscle issues - promotes angiogenesis and growth factor expression

  • Joint problems

    Arthritis support, joint pain, cartilage issues - anti-inflammatory and regenerative properties

  • Post-surgical recovery

    Accelerating healing after procedures - works systemically to enhance the body's repair mechanisms

Consider alternatives if

Growth hormone optimizationCJC-1295Ipamorelin
Cognitive enhancementSemaxSelank
Anti-aging / skinGHK-CuEpithalon

Do not use if

  • Pregnancy
  • Breastfeeding
  • Active cancer
  • History of cancer

Use with caution if

  • You have any chronic medical conditions
  • You are taking prescription medications
  • You have a history of allergic reactions to peptides

Not sure?

Compare BPC-157 with similar peptides to find the best fit for your goals.

Route

Subcutaneous injection

Into the fatty tissue just under the skin.

Best sites

  • Lower abdomen (2 inches from navel)
  • Outer thigh (middle third)
  • Back of upper arm

The BPC-157 injection guide covers reconstitution · step-by-step technique · storage · a sample daily schedule.

3 common side effects · 2 serious

Emergency signs first, then what this page and MedlinePlus say.

BPC-157 is a gastric pentadecapeptide with strong preclinical evidence from extensive animal studies spanning over 25 years of research.

Critical limitation: BPC-157 has NOT completed Phase 3 human clinical trials. No FDA approval exists. Safety data comes primarily from rat and mouse studies, with only limited Phase 1-2 human data.

Animal studies show no toxicity at therapeutic doses, but human data is insufficient for regulatory approval. The peptide is unregulated, and no standardized manufacturing or quality control requirements exist for research compounds.

Individual responses may vary significantly, and serious medical supervision is essential before use, particularly if you have gastrointestinal conditions, take medications, or have pre-existing medical conditions.

BPC-157's evidence base is categorized as 'Strong preclinical' based on extensive rat models demonstrating accelerated healing across multiple tissue types including tendon, ligament, muscle, and GI mucosa. However, no completed Phase 3 human clinical trials exist.

Published human data is limited to a small number of early-phase studies and case reports. Manufacturing quality varies significantly between suppliers as the compound is not regulated by the FDA .


Common side effects · experienced by some users

Injection site redness

Usually resolves in 30-60 minutes

Management
Rotate sites, ice if needed

Mild nausea

Typically only first few doses

Management
Take with food, reduce dose temporarily

Dizziness

Rare, usually with higher doses

Management
Reduce dose, stay hydrated

Serious side effects

Allergic reaction

Rare but serious allergic reactions may include difficulty breathing, facial swelling, or anaphylaxis. Seek immediate medical attention if experienced.

Management
This is a medical emergency. Call 911 or go to the nearest emergency room immediately. If you have an EpiPen available, use it. Stop BPC-157 use immediately and inform medical staff that you were using a peptide therapeutic compound.

Less commonHeadacheFatigueHot/cold sensations

These typically resolve with continued use or dose adjustment.


Stop and seek help if

  • If you experience severe or persistent injection site reactions or signs of infection
  • If you develop signs of an allergic reaction such as difficulty breathing, swelling, or severe rash
  • If healing progress plateaus after 6+ weeks of continuous use, indicating need for reassessment or alternative approaches

Always consult with a healthcare provider before discontinuing BPC-157, especially if used for active injury recovery. Do not stop abruptly without medical guidance as this may impact healing outcomes.


With other peptides

With medications

  • CautionBlood Thinners (Warfarin
  • Cautionetc.)
  • CautionNSAIDs (Ibuprofen

With supplements

  • SafeVitamin D3 — Generally safe and may support overall health
  • SafeMagnesium — Generally safe and may enhance peptide absorption

Strong preclinical · first signs week 1-2

Evidence level

Strong preclinical

(extensive animal studies)

70/100

Regulatory status

Research compound

Onset of effects

Moderate

(1-2 weeks)


How it works

BPC-157 works by interacting with specific receptors and signaling pathways in your body.

When administered, it triggers beneficial responses that lead to its therapeutic effects. Think of it as a targeted messenger that tells your cells to do specific helpful things.

The deeper mechanism

BPC-157 exerts its effects through receptor-mediated signaling cascades. The peptide binds to its target receptor(s), initiating intracellular signaling that ultimately produces the observed physiological effects. Research continues to fully characterize the complete mechanism of action.


What to expect

  1. Week 1-2

    What you might notice

    • Reduced inflammation
    • Less pain at injury site
    • Improved gut comfort (if used for digestive issues)

    What's normal

    • Subtle changes—don't expect dramatic results yet
    • Some users feel nothing this early

    What's next

    • Continue protocol
    • Maintain consistent timing
  2. Week 3-4

    What you might notice

    • Noticeable improvement in injury healing
    • Increased mobility
    • Better function in affected area
    • Significant gut symptom relief

    What's normal

    • This is when most users see clear benefits
    • Progress may be gradual, not sudden

    What's next

    • Assess if dose adjustment needed
    • Continue if seeing progress
  3. Week 5-6+

    What you might notice

    • Substantial or complete healing
    • Return to normal activity
    • Lasting improvements

    What's normal

    • Healing timeline varies by injury severity
    • Some chronic conditions need longer

    What's next

    • Consider stopping if healed
    • Take 2-4 week break
    • Can restart if needed

Signs it's working

For injuries

  • Less pain at rest
  • Less pain with movement
  • Improved range of motion
  • Faster recovery between workouts
  • Reduced swelling

Signs it's working

For gut issues

  • Less bloating
  • Reduced pain after eating
  • More regular digestion
  • Decreased symptoms overall

Not seeing results?

Common reasons

  • Not allowing enough time—most peptides require consistent use for weeks to months before full effects are apparent
  • Inconsistent dosing schedule—maintaining regular administration is critical for optimal results
  • Improper storage or handling leading to degraded product
  • Individual variation in response—genetics, health status, and other factors affect how you respond
  • Dose may need adjustment—consult with your healthcare provider about optimizing your protocol

2 registered studies, 1 still enrolling.

2registered studies
1recruiting now
0phase 3 or 4
0with published results

By phase

Phase 1

1

Phase 2

1

A trial spanning two phases is counted in both, so these can sum above the total. Observational studies carry no phase.

What kind of research

Gave the drug

2

Records only

0

About 162 people took part in the studies that actually administered BPC-157. Observational studies analyse the records of people already taking it — nobody was given anything for the study, so they are counted separately and cannot show cause and effect.


Most recent

  • NCT07437547 Phase 2Recruiting120 enrolled

    BPC 157 for Acute Hamstring Muscle Strain Repair

    Hudson Biotech

  • NCT02637284 Phase 1Unknown42 enrolled

    PCO-02 - Safety and Pharmacokinetics Trial

    PharmaCotherapia d.o.o.

See all 2 trials for BPC-157

Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered twice is counted once. A study is counted when BPC-157 is named as an intervention; studies that only mention it in passing are not.

How long does BPC-157 take to work?

Most users begin noticing effects within 1-2 weeks, with significant improvements typically occurring around weeks 3-4. For severe or chronic injuries, it may take 6-8 weeks for full benefits.

Can I take BPC-157 orally?

While some research shows oral BPC-157 may be effective for gut issues, subcutaneous injection is generally preferred for systemic and localized healing as it provides more reliable absorption .

Should I inject near the injury site?

Injecting near the injury site can provide localized benefits, but BPC-157 also works systemically. Many users alternate between local and abdominal injections.

Can I stack BPC-157 with other peptides?

Yes, BPC-157 is commonly stacked with TB-500 for enhanced healing. It can also be used alongside growth hormone secretagogues without issues.

Do I need to cycle BPC-157?

Cycling is recommended. A typical protocol is 4-6 weeks on, followed by 2-4 weeks off before restarting if needed. This helps maintain effectiveness and allows assessment of healing progress.

Ready for the protocol?

Every dosing tier, administration route, timing note, and dose-adjustment rule for BPC-157, on one page.

BPC-157 dosing protocol

Medical disclaimer

BPC-157 is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: Oct 9, 2026

250 – 500 mcg Once daily or twice daily · onset 1-2 weeks
Open the BPC-157 calculatorBPC-157 calculator